News Image

BOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical Setup

By Mill Chart

Last update: Jul 16, 2025

BOSTON SCIENTIFIC CORP (NYSE:BSX) stands out as a compelling candidate for high-growth momentum investors, combining strong earnings momentum with a favorable technical setup. The company, a leader in medical device innovation, has demonstrated consistent growth in earnings and revenue while presenting a well-defined consolidation pattern on the charts.

BOSTON SCIENTIFIC stock chart

Growth Momentum Highlights

  • Earnings Growth: BSX reported a 26.2% year-over-year EPS growth (TTM), with recent quarterly EPS growth accelerating to 33.9%.
  • Revenue Strength: Sales growth remains robust, with a 19.4% increase over the past year and a 20.9% jump in the most recent quarter.
  • Profit Margin Expansion: The company has improved its quarterly profit margin from 7.9% a year ago to 14.5% in the latest quarter.
  • Positive Revisions: Analysts have raised next-year EPS estimates by 2.0% over the past three months, reflecting confidence in continued growth.
  • Consistent Earnings Beats: BSX has surpassed EPS estimates in each of the last four quarters, with an average beat of 7.1%.

Technical Strength & Setup

  • Technical Rating (7/10): BSX maintains a solid uptrend, outperforming 83% of its peers in the Health Care Equipment & Supplies industry.
  • Setup Rating (8/10): The stock is consolidating within a defined range ($100.34 - $107.53), offering a potential breakout opportunity.
  • Support & Resistance: Key support lies near $102.61, while resistance sits around $103.69. A breakout above resistance could signal further upside.
  • Recent Pocket Pivot: A bullish accumulation signal was recently detected, reinforcing the positive setup.

For a deeper technical analysis, review the full technical report for BSX.

Our High Growth Momentum Breakout Setups Screen identifies more stocks with similar growth and technical characteristics.

Disclaimer

This is not investment advice. The observations are based on current data, but investors should conduct their own research before making decisions.